天津发展(00882)附属斥资3000万元认购兴业银行理财产品

Core Viewpoint - Tianjin Development (00882) has announced an investment of RMB 30 million (approximately HKD 32.82 million) in a fixed-income investment product through its indirect non-wholly owned subsidiary, Lifescience Pharmaceutical, in collaboration with Industrial Bank and its wealth management division [1] Group 1 - The investment agreement is the eleventh of its kind between Lifescience Pharmaceutical and Industrial Bank [1] - The transaction is set to take place on November 19, 2025 [1]